MetLife (NYSE: MET) director gains 7 shares via deferred compensation plan

Rhea-AI Filing Summary

MetLife director Daniel S. Glaser reported a small share award. On June 9, 2026, he acquired 7 shares of MetLife common stock at $85.57 per share through a grant tied to the MetLife Deferred Compensation Plan for Non-Management Directors. After this award, he holds 2,108 shares directly and 198 shares indirectly in a GRAT.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Glaser Daniel S

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7	$85.57	$598.99
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,108 shares (Direct, null); Common Stock — 198 shares (Indirect, By GRAT)

Footnotes (1)

1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. These shares are held in a GRAT.

Key Figures

Share award: 7 shares Award price: $85.57 per share Direct holdings after: 2,108 shares +2 more

5 metrics

Share award 7 shares Grant, award, or other acquisition of common stock

Award price $85.57 per share Price per share for 7-share grant

Direct holdings after 2,108 shares Total MetLife common stock held directly after award

Indirect GRAT holdings 198 shares MetLife common stock held indirectly in a GRAT

Transaction date June 9, 2026 Date of reported Form 4 transactions

Key Terms

Grant, award, or other acquisition, GRAT, MetLife Deferred Compensation Plan for Non-Management Directors, deferred shares

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

GRAT financial

"These shares are held in a GRAT."

MetLife Deferred Compensation Plan for Non-Management Directors financial

"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors."

deferred shares financial

"Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Daniel S

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A(1)		7	A	$85.57	2,108	D
Common Stock								198(2)	I	By GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

2. These shares are held in a GRAT.

Remarks:

The reporting person's disclosure rounds deferred shares to the nearest whole number.

	/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MetLife (MET) director Daniel S. Glaser report in this Form 4?

Daniel S. Glaser reported receiving 7 shares of MetLife common stock as a grant. The shares were tied to the MetLife Deferred Compensation Plan for Non-Management Directors and reflect imputed reinvestment of dividends on deferred shares.

How many MetLife (MET) shares did Daniel S. Glaser acquire and at what price?

He acquired 7 shares of MetLife common stock at a price of $85.57 per share. The transaction is coded as a grant or award rather than an open-market purchase, indicating compensation-related share accrual.

How many MetLife (MET) shares does Daniel S. Glaser hold after this transaction?

Following the transaction, he holds 2,108 MetLife common shares directly. In addition, 198 MetLife shares are held indirectly in a grantor retained annuity trust (GRAT), giving context to both his direct and indirect ownership.

What is the MetLife Deferred Compensation Plan for Non-Management Directors?

It is a plan under which MetLife non-management directors defer certain compensation into deferred shares. Dividends on these deferred shares are imputed and reinvested, creating additional common shares whose receipt the director has elected to defer.

What does it mean that some MetLife (MET) shares are held in a GRAT?

A GRAT, or grantor retained annuity trust, is an estate-planning vehicle that can hold company shares. In this filing, 198 MetLife common shares are held in a GRAT associated with Daniel S. Glaser, reflecting indirect ownership of those shares.